Operation Warp Speed

Operation Warp Speed

Operation Warp Speed is a public–private partnership, initiated by the federal government of the United States, to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. It was introduced by the Trump administration in early April 2020. Operation Warp Speed will promote mass production of multiple vaccines based on preliminary evidence allowing for faster distribution if clinical trials confirm one of the vaccines is safe and effective. The plan anticipates that some of these vaccines will not prove safe or effective, making the program more costly than typical vaccine development, but potentially leading to the availability of a viable vaccine several months earlier than typical timelines. Congress has allocated nearly $10 billion for Operation Warp Speed with $6.5 billion designated by Congress for countermeasure development through BARDA, along with $3 billion for NIH research.Operation Warp Speed is an interagency program that includes components of the Department of Health and Human Services, including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the National Institutes of Health, and the Biomedical Advanced Research and Development Authority (BARDA); the Department of Defense; private firms; and other federal agencies, including the Department of Agriculture, the Department of Energy, and the Department of Veterans Affairs.

Update this biography »
Complete biography of Operation Warp Speed »